MAK Capital Fund LP 13D and 13G filings for Autolus Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 3:04 pm Purchase | 2026-03-31 | 13G | AUTOLUS THERAPEUTICS PLC SPONS AUTL | MAK Capital Fund LP | 33,621,487 12.600% | 3,616,144 (+12.05%) | Filing |
| 2026-02-13 4:07 pm Purchase | 2025-12-31 | 13G | AUTOLUS THERAPEUTICS PLC SPONS AUTL | MAK Capital Fund LP | 30,005,343 11.300% | 3,117,835 (+11.60%) | Filing |
| 2025-12-03 4:04 pm Purchase | 2025-12-01 | 13G | AUTOLUS THERAPEUTICS PLC SPONS AUTL | MAK Capital Fund LP | 26,887,508 10.100% | 11,478,870 (+74.50%) | Filing |
| 2025-06-25 6:36 pm Purchase | 2025-06-17 | 13G | AUTOLUS THERAPEUTICS PLC SPONS AUTL | MAK Capital Fund LP | 15,408,638 5.800% | 15,408,638 (New Position) | Filing |